Halie May’s Post

The Sequence for the week of 6/24-6/30 discusses a potential workflow for PGx testing in the context of testing for patients who take antipsychotic drugs. I discuss why the widespread implementation of pharmacogenetics has yet to occur and one of the barriers to adopting PGx testing. #genetics, #publicpolicy, #geneticcounseling, #precisionmedicine, #translationalmedicine, #genetictesting, #pharmacogenetics, #pharmacogenetictesting, #testinglimitations, #CYP2D6

The Sequence for the week of 6/3-6/9 discusses a new reason for a potential false-positive on newborn screening. As with screening of all kind, newborn screening has its limitations. In this case, we have an opportunity to learn from false-positive tests for X-linked ALD. #genetics, #publicpolicy, #geneticcounseling, #precisionmedicine, #translationalmedicine, #genetictesting, #newbornscreening, #ALD, #testinglimitations, #autoimmunedisease

The Sequence for the week of 5/27-6/2 discusses the motivators and barriers around hereditary genetic testing, and the variety of reasons so many patients who could benefit from genetic testing don't opt for it. Read on for more! #genetics, #publicpolicy, #geneticcounseling, #precisionmedicine, #translationalmedicine, #genetictesting, #inheritedcancergenetictesting, #inheritedcancer, #barriers, #motivators

The Sequence for the week of 5/13-5/19 takes a look at a new tool that can predict the shapes and interactions of biomolecules to understand the way they bind with one another. This innovation could mean predicting how those molecules interact together in drug development. #genetics, #publicpolicy, #geneticcounseling, #precisionmedicine, #translationalmedicine, #genetictesting, #geneticresearch, #proteinfolding, #ai, #deeplearning, #modeling, #drugdevelopment

I've already learned so much from spending just a few days on this incredibly talented and empathetic team of clinical oncology specialists! I can't wait to continue growing alongside them and continue to learn. #natera #empower